|
1. Heart Disease and Stroke Statistics - 2008 Update from the American Heart Association
2. Mosca L et al. Tracking Women's Awareness of Heart Disease : An American Heart Association National Study. Circulation. 2004;109:573-579
3. Ross R., et. al. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126
4. Solomon SD, Lin J, Solomon CG, et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 12/4/2007
5. Wang TJ, et al. Biomarkers that predicted risk of cardiovascular events. N Engl J Med 12/21/2006; 355:2631-2639.
6. Khera, A. et al., Relationship Between C-Reactive Protein and Subclinical Atherosclerosis:
The Dallas Heart Study. Circulation 2006;113:38-43.
7. Pearson TA, et. al., AHA/CDC Panel: Recommendations for hs-CRP Laboratory Testing. Circulation. 2003; 107:499-511.
8. N Engl J Med. 10/2000; 343:1148-1155. Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention. Available at: http://www.ajconline.org/article/S0002-9149(08)00686-3/fulltext
9. Serruys, Patrick W., et. al.; Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque. Circulation. 9/9/2008;118:1172-1182
10. Nicholls,SJ; Hazen,SL; Myeloperoxidase and Cardiovascular Disease. Arterioscler. Thromb. Vasc. Biol. 3/2005;25:1102-1111
|